Your basket is currently empty!
ALLO-316 Demonstrates Antitumor Activity in Advanced ccRCC
Data Provide Proof-of-Concept for an Allogeneic Anti-CD70 CAR T Candidate in Patients with Renal Cell Carcinoma ...
News Archive
Month: April 2023
Belzutifan+cabozantinib shows promise for advanced RCC, study shows
belzutifan+cabozantinib combination therapy show promise as an option for advanced kidney cancer patients already ...
No results found.